73,50 €
2,40 % gestern
L&S, 3. Mai, 22:54 Uhr
ISIN
US5898891040
Symbol
MMSI
Berichte

Merit Medical Systems, Inc. Aktie News

Neutral
Seeking Alpha
4 Tage alt
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q1 2024 Earnings Conference Call April 30, 2024 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman, and CEO Brian Lloyd - CLO and Corporate Secretary Joe Wright - CCO Raul Parra - CFO Conference Call Participants Craig Bijou - Bank of America Securities Jason Bednar - Piper Sandler Jason Bedford - Raymond James Steve Lichtman - Oppen...
Neutral
GlobeNewsWire
4 Tage alt
* Constant currency revenue; constant currency revenue, organic; non-GAAP gross profit and margin; non-GAAP operating income and margin; non-GAAP net income; non-GAAP EPS; and free cash flow are non-GAAP financial measures. A reconciliation of these financial measures to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.
Neutral
GlobeNewsWire
etwa 2 Monate alt
Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases Micro ACE combines a unique balance of stiffness and resiliency to achieve successful micro-access in challenging cases
Neutral
GlobeNewsWire
etwa 2 Monate alt
SOUTH JORDAN, Utah, March 18, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2024, after the close of the stock market on Tuesday, April 30, 2024.
Neutral
GlobeNewsWire
2 Monate alt
Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320 Merit Medical to host SIR attendees at Salt Lake City headquarters and SIR booth 320
Neutral
Seeking Alpha
2 Monate alt
Merit Medical Systems, Inc. (MMSI) Q4 2023 Earnings Call Transcript
Neutral
GlobeNewsWire
2 Monate alt
SOUTH JORDAN, Utah, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today introduced its Continued Growth Initiatives Program and related financial targets for the three-year period ending December 31, 2026.
Neutral
GlobeNewsWire
2 Monate alt
*  Constant currency revenue; constant currency revenue, organic; non-GAAP EPS; non-GAAP net income; non-GAAP operating income and margin; non-GAAP gross profit and margin; and free cash flow are non-GAAP financial measures. A reconciliation of these financial measures to their most directly comparable GAAP financial measures is included under the heading “Non-GAAP Financial Measures” below.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen